PCSK9 inhibitors: clinical evidence and implementation
- Authors
- BA Ference
- BA Ference
- C Landlinger
- Cholesterol Treatment Trialists’ (CTT) Collaboration
- CP Cannon
- CP Cannon
- DJ Kereiakes
- DS Kazi
- DS Kazi
- E Stroes
- EA Bohula
- EA Stein
- EM Roth
- EM Roth
- EP Navarese
- FJ Raal
- FJ Raal
- FJ Raal
- FM Sacks
- GC Fonarow
- GG Schwartz
- Heart Protection Study Collaborative Group
- HN Ginsberg
- J Cohen
- JC Cohen
- JC LaRosa
- JD Horton
- JG Robinson
- JG Robinson
- JJ Kastelein
- K Fitzgerald
- KK Ray
- KN Maxwell
- KN Maxwell
- L Bowman
- Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
- M Abifadel
- M Dellborg
- M Varret
- Marc S. Sabatine
- MG Silverman
- MJ Koren
- ML Hartgers
- MP Bonaca
- MP Bonaca
- MP Bonaca
- MS Sabatine
- MS Sabatine
- MS Sabatine
- MS Sabatine
- MS Sabatine
- MS Sabatine
- NR Desai
- NR Desai
- PI Thakore
- PM Moriarty
- PM Ridker
- PM Ridker
- PM Ridker
- PM Ridker
- Q Ding
- R Collins
- RP Giugliano
- RP Giugliano
- RP Giugliano
- RP Giugliano
- S Bansilal
- S Kathiresan
- S Wasserman
- Scandinavian Simvastatin Survival Study Group
- SD Wiviott
- SD Wiviott
- SE Nissen
- X Wang
- Y Pan
- Publication date
- Publisher
- 'Springer Science and Business Media LLC'
- Doi
Abstract
Abstract is not available.Similar works
Available Versions
Last time updated on 30/10/2020